PINXF vs GS: Which Stock is Better?
Side-by-side comparison of The People's Insurance Company (Group) of China Limited and Goldman Sachs Group Inc in 2026
PINXF
The People's Insurance Company (Group) of China Limited
$0.75
GS
Goldman Sachs Group Inc
$925.95
Key Metrics Comparison
| Metric | PINXF | GS | Winner |
|---|---|---|---|
| Market Cap | $43.78B | $267.08B | GS |
| P/E Ratio | 5.02 | 16.45 | PINXF |
| EPS (TTM) | $0.15 | $54.72 | GS |
| Revenue Growth | -0.0% | 0.1% | GS |
| Gross Margin | 14.6% | 82.3% | GS |
Analyze PINXF
Full quant analysis
Analyze GS
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PINXF or GS a better investment?
Comparing PINXF and GS: The People's Insurance Company (Group) of China Limited has a market cap of $43.78B while Goldman Sachs Group Inc has $267.08B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PINXF and GS?
PINXF (The People's Insurance Company (Group) of China Limited) and GS (Goldman Sachs Group Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PINXF or GS?
Based on P/E ratios, PINXF trades at a lower multiple (5.0x vs 16.4x).
Which is growing faster: PINXF or GS?
GS has higher revenue growth at 0.1% vs -0.0% for PINXF.
Which company is more profitable: PINXF or GS?
Goldman Sachs Group Inc (GS) has higher gross margins at 82.3% compared to 14.6% for PINXF.
Which is the larger company: PINXF or GS?
Goldman Sachs Group Inc (GS) is larger with a market cap of $267.08B compared to $43.78B for PINXF.
Should I buy PINXF or GS in 2026?
Both PINXF and GS have investment merit. PINXF trades at $0.75 while GS trades at $925.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PINXF and GS stock?
Key differences: Market Cap ($43.78B vs $267.08B), P/E Ratio (5.0x vs 16.4x), Revenue Growth (-0.0% vs 0.1%), Gross Margin (14.6% vs 82.3%).